ICVX
- Icosavax, Inc.
()
Overview
Company Summary
Icosavax, Inc. (ICVX) is a biotechnology company that specializes in the development of innovative vaccines. The company's primary focus is on creating safe and effective vaccines to combat infectious diseases.
Icosavax applies cutting-edge technologies and scientific expertise to design and develop novel vaccine candidates. Their approach involves utilizing virus-like particle (VLP) technology, which mimics the structure of viruses without causing disease. By manipulating VLPs, they are able to create immunogenic vaccine candidates that elicit a strong immune response.
The company's pipeline includes vaccines targeting diseases such as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), which are significant causes of respiratory infections, particularly in infants and the elderly. They are also investigating the potential of their VLP platform for use in other infectious diseases.
The goal of Icosavax is to address unmet medical needs by developing vaccines that are safe, efficient, and can provide long-lasting protection against infectious diseases. By leveraging their expertise and technology, the company aims to make a positive impact on public health and contribute to the prevention and control of various diseases.